Periodic monitoring Active

Key facts

  • In November 2025, 12 EU/EEA countries reported 83 measles cases. Eighteen countries reported zero cases.
  • During the last 12-month period, 10 deaths attributable to measles were reported to ECDC by Romania (5), France (4) and the Netherlands (1).
  • Overall, case numbers decreased compared with the previous months, which is consistent with the seasonality of measles.
  • Supplementary epidemic intelligence surveillance was performed between 15 and 16 January 2026. Sporadic cases and clusters were reported in several EU/EEA countries. No new outbreaks have been detected. Updates are provided for countries outside the EU/EEA.

Overview

Since March 2025, there has been an overall decrease in reported measles cases. As expected, the number of cases further declined over the summer months, in line with the known seasonality of the disease.

In November 2025, 30 EU/EEA countries reported measles data, with 12 countries reporting 83 cases. Eighteen countries reported zero cases.

Overall, case numbers decreased compared with the previous month; however, this is subject to change in the event of a future retrospective update. The highest case counts were reported by Poland (30), Germany (16), Italy (11) and Spain (10).

Between 1 December 2024 and 30 November 2025, 30 EU/EEA countries reported a total of 8 826 measles cases, 6 357 (72.0%) of which were laboratory confirmed.

Of the 8 826 cases with known age, 3 533 (40.0%) were in children under five years old; 2 973 (33.7%) cases were in individuals 15 years old or above. The highest notification rates were observed among infants under one year old (292.9 cases per million population) and children one to four years old (148.3 cases per million population).

Of 8 342 cases (94.5% of all cases) with known age and vaccination status, 6 788 (81.4%) were unvaccinated, 811 (9.7%) were vaccinated with one dose of a measles-containing vaccine, 608 (7.3%) were vaccinated with two or more doses, and 121 (1.5%) were vaccinated with an unknown number of doses.

During the 12-month period, 10 deaths (case fatality rate (CFR): 0.113%) attributable to measles were reported to ECDC by Romania (5), France (4) and the Netherlands (1). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance was conducted, with data collection between 15 and 16 January 2026. No new outbreaks have been detected; sporadic cases and clusters have been reported by several EU/EEA countries. Outside the EU/EEA, updates have been provided for Canada, England, Israel, Mexico, Ukraine, and the United States (US), as well as and for the Africa CDC and World Health Organization Pan American Health Organization (WHO PAHO) regions.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Austria reported two new cases in 2026 (from 1 January 2026 to 14 January 2026). In 2025, Austria reported 152 measles cases.

Denmark reported 12 cases in 2025 (data access date: 15 January 2026), an increase of three cases since November 2025.

Estonia reported 11 cases in 2025 (data access: 15 January 2026), an increase of four cases since the previous report.

France reported 868 cases from 1 January to 30 November 2025, including four deaths (all in immunocompromised patients), an increase of 10 cases and two deaths since 31 October 2025. Of the reported cases, 113 were clustered cases.

Germany reported 283 confirmed and probable cases in 2025 (weeks 1–52), an increase by five cases since 9 December 2025. In 2026, 11 confirmed and probable cases have been reported form weeks 1–3. No outbreaks have been detected by the ECDC Epidemic Intelligence group.

 

Ireland reported two cases in week 53 in 2025 and no new cases in the last 12 weeks. 

Italy reported 485 cases (454 laboratory confirmed, 11 probable and 20 possible) from 1 January to 30 November 2025, an increase of 26 cases since 30 September 2025. Of the reported cases, 73 were imported and 26 were related to imported cases. Of the laboratory-confirmed cases, 62% were genotyped, with 131 samples positive for genotype D8 and 144 for genotype B3.

Lithuania reported 11 cases in 2025, an increase of two cases since 7 October 2025. In 2026, and as of 15 January 2026, no new cases have been reported.

The Netherlands reported 539 cases in 2025 and no new cases in 2026 as of 7 January 2026, an increase of one case since 3 December 2025. There is no indication of a national outbreak. In 2025, 62 cases contracted measles abroad, with most of these infections related to travel to Morocco (39). Other cases had travel histories to Greece, Romania, Vietnam, Türkiye, Belgium, Uganda, Iran, Bosnia and Herzegovina, China, Malaysia, France, Somalia and Italy.

Poland reported 127 cases, an increase of 26 cases between 30 November and 31 December 2025. The 26 cases are related to the previously reported outbreak in Podkarpackie Voivodeship.

Romania reported 8 472 cases and eight deaths in 2025 and, as of 31 December 2025, an increase of 18 cases since 30 November 2025. No new deaths were reported in this period. The number of cases has decreased considerably in the past five months, with fewer cases reported per month compared with the same period in 2024.

 

Spain reported 397 cases in 2025, an increase of seven cases from 30 November to 28 December 2025. Of these reported cases, 108 were imported and 95 were related to imported cases. In 2026, there were no new cases reported as of 11 January 2026.

Sweden reported nine cases in 2025, as of 15 January 2026, a decrease of one case since the beginning of December 2025.

Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:

No new outbreaks or cases have been detected in the recently reported outbreaks during this reporting period.

Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:

England reported 957 laboratory-confirmed cases from January 2025 to the week starting on 5 January 2026, 110 more cases since 20 November 2025. The majority of cases involve children under 10 years old (69%). Most of the cases have been reported in Hackney, the City of London, Birmingham and Bristol. In 2024, England reported 2 911 laboratory-confirmed cases, the highest number of cases reported annually.

Israel reported 878 measles hospitalisations in 2025 and as of 12 January 2026, including 13 deaths from measles.

Ukraine reported 1 456 measles cases from January to November 2025, an increase of three cases since October 2025.

Canada reported 5 425 cases (5 045 confirmed, 380 probable) in 2025 (as of 3 January 2026). Two deaths have been reported. Both deaths occurred in congenital cases of measles, where the babies were born pre-term. Cases have been reported in 10 jurisdictions. Overall, the number of cases has decreased in Canada since the peak in week 18 2025.

As of 14 January 2026, the US reported 171 new confirmed cases in 2026, reported from five jurisdictions, and no new outbreaks. In 2025, the US reported 2 242 confirmed cases, including three deaths, in 45 jurisdictions. The majority of the cases in 2025 (89%) were associated with 49 outbreaks.

As of 15 January 2026, Mexico, in 2025, reported 6 427 confirmed cases, including 24 deaths. Most of the cases were reported in the Chihuahua region (4 490 confirmed cases, including 21 deaths). One death was reported in each of the following states: Jalisco, Durango and Sonora. In 2026 (weeks 1–2), 459 cases were reported and no deaths. Most of the cases in 2026, in Mexico, were reported in the Jalisco (252) and Chiapas (111) regions.

According to a report by Africa CDC published on 24 December 2025, Mali and Mozambique are experiencing measles outbreaks with moderate risk.

According to the WHO PAHO report published on 3 January 2026 (data for weeks 1–53, 2025), 14 504 confirmed cases were reported by 13 countries, with the majority of cases being reported in Canada (5 425), Mexico (6 152), the United States (2 144) and Bolivia (595).

For more information on the provisional number of cases outside the EU/EEA region, please visit the World Health Organization (WHO) website.

The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

ECDC assessment

Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.

Continued vigilance is essential due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, possible introduction from areas with ongoing transmission, and increased travel and population movement during the holiday period.

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs of measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.

ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for measles-containing vaccines (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
  • Healthcare professionals should be fully vaccinated.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with populations underserved by healthcare services. Systemic barriers that affect vaccine uptake in populations that are isolated and underserved by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
  • In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up-to-date with recommended immunisations prior to departure.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.

Latest updates for this event

View all